Sotera Health reprices $1.42B term loan, reducing interest rate by 25 basis points
SHC sits 44% above its 52-week low of $10.795.
Summary
Sotera Health repriced $1.42 billion in term loans, cutting the interest rate spread by 0.25% and reducing annual interest expenses by approximately $3.54 million.
Key Events · Financing and Capital Events · SHC
-
Debt Repricing
Sotera Health amended its First Lien Credit Agreement, repricing approximately $1.42 billion in term loans.
-
Interest Rate Reduction
The interest rate spread on these term loans was reduced by 0.25% (25 basis points), from Adjusted Term SOFR plus 2.50% to Adjusted Term SOFR plus 2.25%.
-
Annual Interest Savings
This repricing is expected to result in annual interest expense savings of approximately $3.54 million.
-
Maturity Date
The repriced term loans mature on May 30, 2031.
Analysis · SHC · Industrial Applications And Services
Sotera Health has successfully repriced a significant portion of its term loans, totaling approximately $1.42 billion. This amendment reduces the interest rate spread by 0.25%, leading to annual interest expense savings of about $3.54 million. This move improves the company's financial efficiency and cash flow, following recent strong quarterly results and the completion of its founding sponsors' share divestment.
At the time of this filing, SHC was trading at $15.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $10.80 to $19.85. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.